Stanley Lee, PhD
Stanley Lee, PhD
Assistant Professor
Translational Science and Therapeutics Division, Fred Hutch
Member
Immunotherapy Integrated Research Center (IIRC), Fred Hutch
Member
Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch
Dr. Stanley Lee studies the molecular basis of blood cell development and how its dysregulation can lead to hematologic malignancies such as myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). His research focuses on defining how disease-causing mutations impact the biology of hematopoietic stem and progenitor cells, and how they drive disease progression and response to therapy. The ultimate goal of Dr. Lee’s research is to translate this knowledge into novel treatments for patients with blood-related disorders including leukemia.
Education
Postdoctoral Fellowship, Memorial Sloan Kettering Cancer Center, 2014-2019
PhD, Walter and Eliza Hall Institute of Medical Research, 2012
MSc (Hons), University of Auckland, 2007
BSc (Hons), University of Auckland, 2005
Research Interests
Understanding and targeting altered RNA processing in hematologic malignancies
Epigenetic regulation of normal and malignant hematopoiesis
Identification and development of novel therapeutic approaches to hematologic malignancies
"I really started to understand that to have the most impactful experiment, you don’t have to have the perfect design. Science doesn’t always have to be beautiful or perfect. It’s even more important to be timely."
— Dr. Stanley Lee
For the Media
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email media@fredhutch.org or call 206.667.2210